These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36681978)
1. Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis. Chiang CL; Yang HC; Luo YH; Chen CJ; Wu HM; Chen YM; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Chou TY; Pan DH; Lee CC J Neurosurg; 2023 Aug; 139(2):385-392. PubMed ID: 36681978 [TBL] [Abstract][Full Text] [Related]
2. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC). Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis. Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940 [TBL] [Abstract][Full Text] [Related]
4. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer. Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792 [TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry. Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684 [TBL] [Abstract][Full Text] [Related]
6. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study. Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723 [TBL] [Abstract][Full Text] [Related]
8. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control. Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939 [TBL] [Abstract][Full Text] [Related]
9. Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era. Cole KL; Earl ER; Findlay MC; Sherrod BA; Tenhoeve SA; Kunzman J; Cannon DM; Akerley W; Burt L; Seifert SB; Goldman M; Jensen RL J Neurooncol; 2024 Sep; 169(3):671-681. PubMed ID: 38951457 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery. Yang WC; Xiao F; Shih JY; Ho CC; Chen YF; Tseng HM; Chen KY; Liao WY; Yu CJ; Yang JC; Kuo SH; Cheng JC; Yang PC; Hsu FM Radiother Oncol; 2018 Feb; 126(2):368-374. PubMed ID: 29111173 [TBL] [Abstract][Full Text] [Related]
12. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer. Bougie E; Masson-Côté L; Mathieu D World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803 [TBL] [Abstract][Full Text] [Related]
13. Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. Pessina F; Navarria P; Cozzi L; Tomatis S; Ascolese AM; Franzese C; Toschi L; Santoro A; De Rose F; Franceschini D; Bello L; Scorsetti M Br J Radiol; 2017 Apr; 90(1072):20170022. PubMed ID: 28256924 [TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC). Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084 [TBL] [Abstract][Full Text] [Related]
15. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases. Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers. Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420 [TBL] [Abstract][Full Text] [Related]
17. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis. Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231 [TBL] [Abstract][Full Text] [Related]
18. Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study. Zhen J; Wen L; Lai M; Zhou Z; Shan C; Li S; Lin T; Wu J; Wang W; Xu S; Liu D; Lu M; Zhu D; Chen L; Cai L; Zhou C Radiat Oncol; 2020 Jul; 15(1):185. PubMed ID: 32736566 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases. Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941 [TBL] [Abstract][Full Text] [Related]
20. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study. Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]